NASDAQ:PGNY Progyny (PGNY) Stock Price, News & Analysis $21.00 +0.38 (+1.84%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Progyny Stock (NASDAQ:PGNY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Progyny alerts:Sign Up Key Stats Today's Range$20.37▼$21.0750-Day Range$13.67▼$21.0052-Week Range$13.39▼$42.08Volume2.92 million shsAverage Volume1.75 million shsMarket Capitalization$1.79 billionP/E Ratio36.21Dividend YieldN/APrice Target$25.00Consensus RatingHold Company OverviewProgyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Read More… Progyny Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks82nd Percentile Overall ScorePGNY MarketRank™: Progyny scored higher than 82% of companies evaluated by MarketBeat, and ranked 209th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingProgyny has received a consensus rating of Hold. The company's average rating score is 2.31, and is based on 4 buy ratings, 9 hold ratings, and no sell ratings.Amount of Analyst CoverageProgyny has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Progyny's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth8.47% Earnings GrowthEarnings for Progyny are expected to grow by 8.47% in the coming year, from $0.59 to $0.64 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Progyny is 36.21, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.81.Price to Earnings Ratio vs. SectorThe P/E ratio of Progyny is 36.21, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.42.Price to Earnings Growth RatioProgyny has a PEG Ratio of 1.95. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioProgyny has a P/B Ratio of 3.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Progyny's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.36% of the float of Progyny has been sold short.Short Interest Ratio / Days to CoverProgyny has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Progyny has recently decreased by 4.59%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldProgyny does not currently pay a dividend.Dividend GrowthProgyny does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.36% of the float of Progyny has been sold short.Short Interest Ratio / Days to CoverProgyny has a short interest ratio ("days to cover") of 6.6.Change versus previous monthShort interest in Progyny has recently decreased by 4.59%, indicating that investor sentiment is improving. News and Social Media3.7 / 5News Sentiment0.66 News SentimentProgyny has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 16 news articles for Progyny this week, compared to 7 articles on an average week.Search Interest8 people have searched for PGNY on MarketBeat in the last 30 days. This is an increase of 167% compared to the previous 30 days.MarketBeat Follows5 people have added Progyny to their MarketBeat watchlist in the last 30 days. Company Ownership4.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Progyny insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,235,560.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders12.30% of the stock of Progyny is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions94.93% of the stock of Progyny is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Progyny's insider trading history. Receive PGNY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Progyny and its competitors with MarketBeat's FREE daily newsletter. Email Address PGNY Stock News HeadlinesInsider Buying: Progyny, Inc. (NASDAQ:PGNY) Chairman Purchases 150,000 Shares of StockDecember 27, 2024 | insidertrades.comProgyny shares surge 54% after November Fair Value signal flagged undervaluationJanuary 19 at 7:28 PM | msn.comCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69% dividend from Tesla… Which could put up to $7,013 in your pocket every month…January 21, 2025 | Investors Alley (Ad)Progyny appoints Morris to board of directorsJanuary 17, 2025 | markets.businessinsider.comFY2024 EPS Estimates for Progyny Raised by Leerink PartnrsJanuary 17, 2025 | americanbankingnews.comProgyny appoints Debra Morris as new board memberJanuary 16, 2025 | msn.comProgyny adds healthcare veteran Debra Morris to boardJanuary 16, 2025 | msn.comProgyny Strengthens Leadership with New Director AppointmentJanuary 16, 2025 | tipranks.comSee More Headlines PGNY Stock Analysis - Frequently Asked Questions How have PGNY shares performed this year? Progyny's stock was trading at $17.25 at the start of the year. Since then, PGNY stock has increased by 21.7% and is now trading at $21.00. View the best growth stocks for 2025 here. How were Progyny's earnings last quarter? Progyny, Inc. (NASDAQ:PGNY) posted its earnings results on Tuesday, November, 12th. The company reported $0.11 EPS for the quarter, missing the consensus estimate of $0.37 by $0.26. The business's quarterly revenue was up 2.0% on a year-over-year basis. When did Progyny IPO? Progyny (PGNY) raised $150 million in an initial public offering (IPO) on Friday, October 25th 2019. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and BofA Merrill Lynch acted as the underwriters for the IPO and Citigroup, Piper Jaffray, SVB Leerink and TPG Capital were co-managers. Who are Progyny's major shareholders? Progyny's top institutional investors include Fort Washington Investment Advisors Inc. OH (1.72%), Nordea Investment Management AB (0.22%), International Assets Investment Management LLC (0.18%) and Janney Montgomery Scott LLC (0.08%). Insiders that own company stock include Tpg Gp A, Llc, Peter Anevski, Michael E Sturmer, Norman Payson, David J Schlanger, Mark S Livingston, Cheryl Scott and Kevin K Gordon. View institutional ownership trends. How do I buy shares of Progyny? Shares of PGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Progyny own? Based on aggregate information from My MarketBeat watchlists, some other companies that Progyny investors own include Humana (HUM), American Water Works (AWK), NVIDIA (NVDA), Rambus (RMBS), Voyager Therapeutics (VYGR), Saia (SAIA) and Waste Connections (WCN). Company Calendar Last Earnings11/12/2024Today1/20/2025Next Earnings (Estimated)2/25/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Miscellaneous health & allied services, not elsewhere classified Sub-IndustryHealthcare Current SymbolNASDAQ:PGNY CUSIPN/A CIK1551306 Webwww.progyny.com Phone212-888-3124FaxN/AEmployees310Year Founded2008Price Target and Rating Average Stock Price Target$25.00 High Stock Price Target$43.00 Low Stock Price Target$17.00 Potential Upside/Downside+19.0%Consensus RatingHold Rating Score (0-4)2.31 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)$0.58 Trailing P/E Ratio36.21 Forward P/E Ratio35.59 P/E Growth1.95Net Income$62.04 million Net Margins5.03% Pretax Margin7.18% Return on Equity11.36% Return on Assets7.87% Debt Debt-to-Equity RatioN/A Current Ratio2.62 Quick Ratio2.62 Sales & Book Value Annual Sales$1.09 billion Price / Sales1.64 Cash Flow$0.75 per share Price / Cash Flow27.95 Book Value$5.77 per share Price / Book3.64Miscellaneous Outstanding Shares85,150,000Free Float74,679,000Market Cap$1.79 billion OptionableOptionable Beta1.31 Social Links The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (NASDAQ:PGNY) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PGNY Stock Alerts